Dalriada is a small molecule drug discovery company supporting global innovators through its TURN-KEY™ model, where R&D is perfectly aligned with business and IP. With all R&D operations in Mississauga, Canada, we build focused expert teams in MedChem, Biology and ADME to allow for the most rapid project advancements and value building. Continuing to innovate alongside start-ups and billion-dollar companies…